282 related articles for article (PubMed ID: 19110622)
21. Efficient lentiviral transduction of liver requires cell cycling in vivo.
Park F; Ohashi K; Chiu W; Naldini L; Kay MA
Nat Genet; 2000 Jan; 24(1):49-52. PubMed ID: 10615126
[TBL] [Abstract][Full Text] [Related]
22. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral gene transfer method to study integrin function in T lymphocytes.
Banerjee D; Shimaoka M
Methods Mol Biol; 2012; 757():47-54. PubMed ID: 21909905
[TBL] [Abstract][Full Text] [Related]
24. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.
Simmons A; Whitehead RP; Kolokoltsov AA; Davey RA
Virol J; 2006 Feb; 3():8. PubMed ID: 16507098
[TBL] [Abstract][Full Text] [Related]
25. T cell culture for gammaretroviral transfer.
Newrzela S; Gunda B; von Laer D
Methods Mol Biol; 2009; 506():71-82. PubMed ID: 19110620
[TBL] [Abstract][Full Text] [Related]
26. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
27. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.
Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A
Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763
[TBL] [Abstract][Full Text] [Related]
28. [Lentiviral vectors].
Spirin PV; Vil'gelm AE; Prasolov VS
Mol Biol (Mosk); 2008; 42(5):913-26. PubMed ID: 18988539
[TBL] [Abstract][Full Text] [Related]
29. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.
Robinet E; Fehse B; Ebeling S; Sauce D; Ferrand C; Tiberghien P
Cytotherapy; 2005; 7(2):150-7. PubMed ID: 16040394
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
31. Current development of lentiviral-mediated gene transfer.
Romano G
Drug News Perspect; 2005 Mar; 18(2):128-34. PubMed ID: 15883621
[TBL] [Abstract][Full Text] [Related]
32. Lentiviral vector transduction of dendritic cells for novel vaccine strategies.
Chang LJ
Methods Mol Biol; 2010; 614():161-71. PubMed ID: 20225043
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells.
Frade R; Rousselet N; Jean D
Cancer Gene Ther; 2008 Sep; 15(9):591-604. PubMed ID: 18617916
[TBL] [Abstract][Full Text] [Related]
34. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
35. Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier.
Grüter O; Kostic C; Crippa SV; Perez MT; Zografos L; Schorderet DF; Munier FL; Arsenijevic Y
Gene Ther; 2005 Jun; 12(11):942-7. PubMed ID: 15772686
[TBL] [Abstract][Full Text] [Related]
36. Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy.
Vargas J; Klotman ME; Cara A
Antiviral Res; 2008 Dec; 80(3):288-94. PubMed ID: 18647620
[TBL] [Abstract][Full Text] [Related]
37. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice.
Themis M; Waddington SN; Schmidt M; von Kalle C; Wang Y; Al-Allaf F; Gregory LG; Nivsarkar M; Themis M; Holder MV; Buckley SM; Dighe N; Ruthe AT; Mistry A; Bigger B; Rahim A; Nguyen TH; Trono D; Thrasher AJ; Coutelle C
Mol Ther; 2005 Oct; 12(4):763-71. PubMed ID: 16084128
[TBL] [Abstract][Full Text] [Related]
38. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model.
Moreno R; Rosal M; Martinez I; Vilardell F; Gonzalez JR; Petriz J; Hernandez-Andrade E; Gratacós E; Aran JM
J Gene Med; 2008 Sep; 10(9):951-64. PubMed ID: 18613266
[TBL] [Abstract][Full Text] [Related]
39. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
Crome SQ; Wang AY; Kang CY; Levings MK
Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
Nanou A; Azzouz M
Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
